Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 10, 2015, Pages 1989-1994

  Matzneller, P ^a   Strommer, S ^a   Osterreicher Z ^a   Mitteregger, D ^a   Zeitlinger, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CATION; COLISTIN; MAGNESIUM ION; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; CULTURE MEDIUM; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULLER HINTON BROTH; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; BACTERIAL INFECTIONS; CELL PROLIFERATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CELL PROLIFERATION; COLISTIN; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA;

EID: 84941414117     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2441-7     Document Type: Article

References (10)

1. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K (2005) Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25(1):11–25. doi:10.1016/j.ijantimicag.2004.10.001
2. Chen CC, Feingold DS (1972) Locus of divalent cation inhibition of the bactericidal action of polymyxin B. Antimicrob Agents Chemother 2(5):331–335
3. Davis SD, Iannetta A, Wedgwood RJ (1971) Activity of colistin against pseudomonas aeruginosa: inhibition by calcium. J Infect Dis 124(6):610–612
4. Newton BA (1953) Reversal of the antibacterial activity of polymyxin by divalent cations. Nature 172(4369):160–161
5. Clinical and Laboratory Standards Institute (CLSI) (2014) Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne, PA
6. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna (2014) Parameter catalogue, reference values. Home page at: http://www.kimcl.at
7. Karvanen M, Malmberg C, Mohamad A, Lagerbäck P, Friberg LE, Cars O (2011) Colistin is extensively lost during normal experimental conditions. Paper presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, September 2011
8. Albur M, Noel A, Bowker K, Macgowan A (2014) Colistin susceptibility testing: time for a review. J Antimicrob Chemother 69(5):1432–1434. doi:10.1093/jac/dkt503
9. Sader HS, Rhomberg PR, Flamm RK, Jones RN (2012) Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin. Diagn Microbiol Infect Dis 74(4):412–414. doi:10.1016/j.diagmicrobio.2012.08.025
10. Hindler JA, Humphries RM (2013) Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol 51(6):1678–1684. doi:10.1128/JCM.03385-12